Breast Cancer
Showing NaN - NaN of 139
Breast Tumors, Breast Tumor Female, Cancer, Breast Trial in Montréal (Thoracic paravertebral block multiple (3) injections,
Recruiting
- Breast Neoplasms
- +3 more
- Thoracic paravertebral block multiple (3) injections
- Thoracic paravertebral block single injection
-
Montréal, Quebec, CanadaCIUSSS de l'Est de l'Île de Montréal
Feb 3, 2023
Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)
Completed
- Breast Cancer
- Stage IV Breast Cancer
- palliative surgery
- +3 more
-
Mobile, Alabama
- +376 more
Jan 6, 2023
Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,
Recruiting
- Breast Neoplasms
- +2 more
- Trastuzumab Deruxtecan
- +5 more
-
Springdale, Arkansas
- +203 more
Jan 13, 2023
Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)
Active, not recruiting
- Breast Cancer
- trastuzumab
- trastuzumab emtansine
-
Anchorage, Alaska
- +275 more
Dec 13, 2022
Developing Cardiotoxicity After Receiving Chemotherapy for
Recruiting
- Breast Cancer
- +2 more
- Cardiac Imaging
- Data Collection
-
Montréal, Quebec, Canada
- +2 more
Dec 20, 2022
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Post-mastectomy Pain Syndrome, Breast Cancer, Pain, Postoperative Trial in Canada (Lidocaine 20mg/ml, Placebo)
Recruiting
- Post-mastectomy Pain Syndrome
- +3 more
- Lidocaine 20mg/ml
- Placebo
-
Calgary, Alberta, Canada
- +11 more
Nov 24, 2022
Local Recurrence Following Breast Conserving Surgery and
Active, not recruiting
- Breast Cancer
-
Calgary, Alberta, Canada
- +26 more
Sep 19, 2022
Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)
Enrolling by invitation
- Ovarian Cancer
- Breast Cancer
-
Boca Raton, Florida
- +98 more
Aug 22, 2022
Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)
Recruiting
- Breast Cancer
- Ipatasertib
- +2 more
-
Bowral, New South Wales, Australia
- +37 more
Aug 8, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Breast Cancer Trial in Worldwide (biological, drug, other, procedure)
Active, not recruiting
- Breast Cancer
- nivolumab
- +6 more
-
Mobile, Alabama
- +255 more
Jul 21, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
HER2 Low and Describe SoC, Treatment Patterns, and Outcome in
Completed
- Breast Cancer
- None (Observational study)
-
Pittsburgh, Pennsylvania
- +12 more
May 25, 2022
Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (T-DXd)
- Ado-trastuzumab emtansine (T-DM1)
-
Los Angeles, California
- +163 more
Apr 1, 2022